rs376706496
Positions:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP6BS2
The NM_000719.7(CACNA1C):c.5144G>A(p.Arg1715Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000236 in 1,607,292 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
CACNA1C
NM_000719.7 missense
NM_000719.7 missense
Scores
2
11
4
Clinical Significance
Conservation
PhyloP100: 5.14
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1C. . Gene score misZ 6.4654 (greater than the threshold 3.09). Trascript score misZ 7.2674 (greater than threshold 3.09). GenCC has associacion of gene with intellectual disability, neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures, Brugada syndrome, long QT syndrome, short QT syndrome, long qt syndrome 8, Timothy syndrome, Brugada syndrome 3.
BP6
Variant 12-2679496-G-A is Benign according to our data. Variant chr12-2679496-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 190685.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS2
High AC in GnomAd4 at 7 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.5378G>A | p.Arg1793Gln | missense_variant | 44/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.5111G>A | p.Arg1704Gln | missense_variant | 41/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.5309G>A | p.Arg1770Gln | missense_variant | 43/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.5288G>A | p.Arg1763Gln | missense_variant | 44/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.5267G>A | p.Arg1756Gln | missense_variant | 42/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.5234G>A | p.Arg1745Gln | missense_variant | 42/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.5234G>A | p.Arg1745Gln | missense_variant | 42/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.5234G>A | p.Arg1745Gln | missense_variant | 42/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.5234G>A | p.Arg1745Gln | missense_variant | 42/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.5228G>A | p.Arg1743Gln | missense_variant | 43/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.5219G>A | p.Arg1740Gln | missense_variant | 43/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.5204G>A | p.Arg1735Gln | missense_variant | 43/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.5201G>A | p.Arg1734Gln | missense_variant | 42/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.5201G>A | p.Arg1734Gln | missense_variant | 42/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.5201G>A | p.Arg1734Gln | missense_variant | 42/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.5195G>A | p.Arg1732Gln | missense_variant | 42/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.5186G>A | p.Arg1729Gln | missense_variant | 42/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.5168G>A | p.Arg1723Gln | missense_variant | 41/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.5168G>A | p.Arg1723Gln | missense_variant | 41/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.5162G>A | p.Arg1721Gln | missense_variant | 41/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.5144G>A | p.Arg1715Gln | missense_variant | 42/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.5135G>A | p.Arg1712Gln | missense_variant | 42/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.5111G>A | p.Arg1704Gln | missense_variant | 41/46 | ENSP00000507309.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152148Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
7
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000166 AC: 4AN: 241542Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131280
GnomAD3 exomes
AF:
AC:
4
AN:
241542
Hom.:
AF XY:
AC XY:
2
AN XY:
131280
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1455144Hom.: 0 Cov.: 31 AF XY: 0.0000180 AC XY: 13AN XY: 722932
GnomAD4 exome
AF:
AC:
31
AN:
1455144
Hom.:
Cov.:
31
AF XY:
AC XY:
13
AN XY:
722932
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74326
GnomAD4 genome
AF:
AC:
7
AN:
152148
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 29, 2016 | The R1715Q variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. However, this variant has been observed in one other unrelated individual referred for Brugada syndrome genetic testing at GeneDx. This variant was not observed at a significant frequency in approximately 6,200 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R1715Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. However, to our knowledge no studies have been performed to determine the functional effect of the R1715Q variant.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or benign. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The p.R1715Q variant (also known as c.5144G>A), located in coding exon 42 of the CACNA1C gene, results from a G to A substitution at nucleotide position 5144. The arginine at codon 1715 is replaced by glutamine, an amino acid with highly similar properties. According to data from gnomAD, the frequency for this variant is above the maximum credible frequency for a cardiac disease-causing variant in this gene based on internally established thresholds (Karczewski et al. Nature. 2020 May;581(7809):434-443; Whiffin et al. Genet Med. 2017 10;19:1151-1158). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, the association of this alteration with CACNA1C-related neurodevelopmental disorder is unknown; however, the association with CACNA1C-related Timothy syndrome or long QT syndrome is unlikely. - |
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;.;.;.;.;.;.;.;.;.;M;.;.;.;.;.;.;.;.;.;.;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;N;D;D;D;D;N;D;D;.
REVEL
Uncertain
Sift
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;D;T;T;T;D;D;D;.
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.95, 0.053, 0.33, 0.092, 0.98, 0.98, 0.97, 0.12, 0.97, 0.97, 1.0, 0.98
.;P;B;B;B;D;D;D;B;D;D;D;D;D;D;.;D;D;.;.;.;P;.
Vest4
MVP
MPC
0.25
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at